ApexOnco Front Page Recent articles 14 July 2025 How MiNK stole the NK T show A single but durable stable disease sends the microcap's stock up 730%. 14 July 2025 Pivotal T-cell engager readouts approach Data on J&J’s Tecvayli and Pfizer’s Elrexfio in relapsed multiple myeloma are due soon. 10 July 2024 Amgen packs up in Claudin6 Meanwhile, Torl BioTherapeutics appears to be catching up with BioNTech. 10 July 2024 Reality Bites again for Amgen Micromet’s tech has yielded two marketed drugs, one still in the clinic... and 14 discontinuations. 10 July 2024 Scancell faces its big decision Data in the coming months will inform which immunotherapy the UK company takes into pivotal development. 9 July 2024 ALX has a Chinese challenger HanchorBio’s HCB301 is among the latest industry projects beginning first-in-human trials. 8 July 2024 Ideaya socks it to GSK Two years after being snubbed by GSK, Ideaya shows the promise of MAT2A inhibition. 5 July 2024 Where next for TIGIT? The implosion of Skyscraper-06 has a direct impact on at least two other TIGIT players. Load More Recent Quick take Most Popular